Literature DB >> 9452997

CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets.

C L Kelleher1, V M Buckalew, E D Frederickson, D J Rhodes, D A Conner, J G Seidman, C E Seidman.   

Abstract

This study demonstrates that a missense mutation in the voltage gated chloride channel, CLCN5, can cause X-linked renal failure without X-linked recessive hypophosphatemic rickets. A large kindred (Family A), initially evaluated in 1974 with an inherited syndrome characterized by hypercalciuria, nephrocalcinosis, low molecular weight proteinuria, renal tubular acidosis, and renal failure, was clinically re-evaluated and genetically characterized. Medical histories, physical examinations, blood chemistries, and 24-hour urine collections were obtained from 48 family members. Both female and male family members exhibited hypercalciuria, nephrolithiasis, and low molecular weight proteinuria. However, only men developed renal insufficiency, consistent with an X-linked recessive gene defect. Genetic linkage located the disease locus on the proximal short arm of the X chromosome (Xp11) where a voltage gated chloride channel gene, CLCN5, had previously been mapped. DNA sequence of the CLCN5 gene demonstrated a missense mutation (Ser244Leu) in affected family members. The same missense mutation has previously been shown to cause X-linked recessive hypophosphatemic rickets. No affected member of Family A had evidence of chronic hypophosphatemia, clinically significant rickets, or osteomalacia. We hypothesize that genetic background, environment, diet, or an unidentified modifying gene may account for the differing phenotypes resulting from this shared gene defect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452997     DOI: 10.1046/j.1523-1755.1998.00752.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  A case of adult Dent disease in Japan with advanced chronic kidney disease.

Authors:  Ken Saida; Yuji Kamijo; Daisuke Matsuoka; Shunsuke Noda; Yoshihiko Hidaka; Tetsuo Mori; Hisashi Shimojo; Takashi Ehara; Kenichiro Miura; Junko Takita; Takashi Sekine; Takashi Igarashi; Kenichi Koike
Journal:  CEN Case Rep       Date:  2013-11-02

2.  Hypercalciuria in patients with CLCN5 mutations.

Authors:  Michael Ludwig; Boris Utsch; Bernd Balluch; Stefan Fründ; Eberhard Kuwertz-Bröking; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

3.  Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.

Authors:  Young H Lim; Diana Ovejero; Jeffrey S Sugarman; Cynthia M C Deklotz; Ann Maruri; Lawrence F Eichenfield; Patrick K Kelley; Harald Jüppner; Michael Gottschalk; Cynthia J Tifft; Rachel I Gafni; Alison M Boyce; Edward W Cowen; Nisan Bhattacharyya; Lori C Guthrie; William A Gahl; Gretchen Golas; Erin C Loring; John D Overton; Shrikant M Mane; Richard P Lifton; Moise L Levy; Michael T Collins; Keith A Choate
Journal:  Hum Mol Genet       Date:  2013-09-04       Impact factor: 6.150

4.  A young man presenting with recurrent nephrolithiasis.

Authors:  Rachel Hellemans; Gert A Verpooten; Jean-Louis Bosmans
Journal:  NDT Plus       Date:  2010-09-15

5.  PHEXL222P Mutation Increases Phex Expression in a New ENU Mouse Model for XLH Disease.

Authors:  Carole El Hakam; Alexis Parenté; Fabienne Baraige; Laetitia Magnol; Lionel Forestier; Florent Di Meo; Véronique Blanquet
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

Review 6.  Proteinuria in Dent disease: a review of the literature.

Authors:  Youri van Berkel; Michael Ludwig; Joanna A E van Wijk; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2016-10-18       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.